March 19, 2026
Phapros Accompanies Homebound Travelers,Strengthens Role as the Community's "Sahabat Sehat"
PT Phapros Tbk (PEHA) reaffirms its commitment to supporting public health through the "Phapros Sahabat Sehat" ...
See More
December 20, 2025
Phapros Introduces New Product for Adult Men's Health at INASAU 2025
PT Phapros Tbk (PEHA) reaffirms its commitment to supporting the improvement of men's health quality through its participation and support at The 4th InaSAU Meeting...
See More
December 12, 2025
Phapros Supports Hydrocephalus Surgery in Tobelo, North Maluku
PT Phapros Tbk (PEHA) once again demonstrated its commitment to supporting the improvement of public health in the eastern region of Indonesia by participating in the "Governor's Christmas Gift in the Month of Love" event....
See More
December 01, 2025
Phapros Records Over 2000% YoY EBITDA Surge and Double-Digit Sales Growth in Q3 2025
PT Phapros Tbk (PEHA), successfully recorded positive performance up to the third quarter of 2025....
See More
November 18, 2025
Phapros Amplifies the Importance of Holistic Health Through Support for the Film "Menuju Pelaminan"
The film, which depicts social conditions and the challenges of cultural differences set against the backdrop of various journeys by land, sea, and air, is highly relevant to Antimo's positioning as a motion sickness medication with the tagline "Family Travel Companion."...
See More
September 17, 2025
Phapros Disburses UMK Funding Program Totaling IDR 2.912 Billion as of September 2025
PT Phapros Tbk, a national pharmaceutical company, once again demonstrates its commitment to supporting the growth of Micro, Small, and Medium Enterprises (UMKM) by distributing partnership funds amounting to IDR 2.9 billion as of September 2025 ...
See More